Saturday 17 October 2026
Export ACON’s income statement to Excel — free account
Aclarion, Inc.
ACON Healthcare Health Information Services
Aclarion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75,700.00, up 65.6% from fiscal 2024. In the quarter to June 2026, revenue grew 30.6%, EPS grew 59.3% and free cash flow fell 41.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.85
0.10
−5.13%
Follow ACON
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 5 | 4 | 4 |
| (98.44%) | (104.89%) | (45.43%) | (58.97%) | ||
| (90.16%) | (91.67%) | (43.37%) | (56.09%) | ||
ROIC |
(378.29%) | (554.92%) | (855.42%) | (876.79%) | |
Return on Tangible Assets |
(65.86%) | (62.50%) | (43.72%) | (58.28%) | |
Average Days of Receivables |
173.29 | 143.20 | 190.48 | 122.97 | |
Free Cash Flow per Share |
(11.47) | (13.86) | (3.50) | (3.36) | |
Free Cash Flow |
(6.68) | (7.37) | (7.45) | (8.26) | |
Capital Expenditures |
(0.22) | (0.21) | (0.15) | (0.17) | |
| Other line items | |||||
Cash ROIC |
(28.00%) | (29.64%) | (19.25%) | (24.80%) | |
Accounts Receivable Turnover |
2.75 | 3.15 | 2.60 | 3.41 | |
Accounts Payable Turnover |
0.24 | 0.16 | 0.11 | 0.13 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,373.88 | 1,761.52 | 3,408.02 | 3,922.64 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1,516.91% | 1,365.52% | 1,479.31% | 1,406.93% | |
Selling, General and Administrative Expense of Revenue |
8,661.42% | 7,959.58% | 9,526.35% | 10,216.49% | |
Share Based Compensation of Revenue |
233.98% | 139.23% | 69.67% | 152.81% | |
Operating CF/Net income |
0.87 | 0.99 | 0.91 | 0.88 | |
Depreciation/Fixed assets |
14.18 | 9.40 | 10.18 | 10.45 | |
Capex/Depreciation |
(1.19) | (0.92) | (0.66) | (0.72) | |
Revenue per Share |
0.12 | 0.14 | 0.04 | 0.03 | |
Operating CF per Share |
(11.09) | (13.47) | (3.43) | (3.28) | |
Capex per Share |
(0.38) | (0.39) | (0.07) | (0.07) | |
Capex to Sales |
3.31 | 2.76 | 1.97 | 2.09 |
Columns are period end dates